Cargando…
Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies
Pemphigus is a rare autoimmune blistering disease, involving potentially life-threatening conditions often requiring immunosuppression. Currently, the COVID-19 pandemic caused by severe acute respiratory disease coronavirus 2 (SARS-CoV-2) infection has become a global public emergency. Vaccines are...
Autores principales: | Huang, Xueyi, Liang, Xiaoqian, Zhang, Jiao, Su, Hang, Chen, Yongfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317200/ https://www.ncbi.nlm.nih.gov/pubmed/35887732 http://dx.doi.org/10.3390/jcm11143968 |
Ejemplares similares
-
On Sporadic and Epidemic Pemphigus
por: Bell, Joseph
Publicado: (1858) -
Management of pemphigus
por: Daniel, Benjamin S., et al.
Publicado: (2014) -
Pemphigus vulgaris and COVID‐19 vaccination: Management and treatment
por: Martora, Fabrizio, et al.
Publicado: (2022) -
Management of Pemphigus Vulgaris
por: Cholera, Mimansa, et al.
Publicado: (2016) -
Pemphigus vulgaris after COVID-19 infection and vaccination
por: Zou, Henry, et al.
Publicado: (2022)